CHLORTHALIDONE REDUCES VASCULAR HYPERRESPONSIVENESS IN DOCA-SALT HYPERTENSIVE RATS

被引:6
|
作者
CABRAL, AM
MUSSO, MN
BISSOLI, NS
CARVALHINHO, FB
VASQUEZ, EC
机构
[1] Dept. Physiological Sciences, Biomedical Center, UFES C.P. 780
关键词
DOCA-SALT HYPERTENSION; CHLORTHALIDONE; VASCULAR REACTIVITY; SEROTONIN; NOREPINEPHRINE; VASOPRESSIN;
D O I
10.3109/10641969209036214
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms of anti-hypertensive effect of diuretics remain unknown. The purpose of this study was to test the hypothesis that long-term treatment with chlorthalidone decreases the responsiveness of resistance vessels to neurohormones. The study was performed in deoxycorticosterone acetate (DOCA)-salt hypertensive rats with and without treatment with chlorthalidone (Chlor. 8 mg/day, for 20 days). Resting mean arterial pressure in freely moving state was significantly reduced in DOCA-salt-Chlor rats when compared to DOCA-salt rats (116+/-3 vs 147+/-7 mmHg, respectively). Chlorthalidone treatment reduced the high plasma sodium content observed in DOCA-salt rats to the same levels observed in normotensive control groups. Results obtained in isolated perfused mesenteric arteries showed: a) the increase in perfusion pressure elicited by norepinephrine (NE), serotonin (SE) and vasopressin (VP) was significantly greater in DOCA-salt than in DOCA-salt+Chlor rats or control normotensive rats; b) the endothelium removal increased the pressor responses to NE, SE and VP in a similar way in all groups. These data provide evidence that long-term chlorthalidone treatment reduces vascular hyperresponsiveness to these neurohormones. In addition, these results indicate that this reduction in vascular hyperresponsiveness, associated with a decrease in extracellular sodium level, could be a possible mechanism by which the diuretics reduce the high blood pressure.
引用
收藏
页码:667 / 683
页数:17
相关论文
共 50 条
  • [41] Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats
    Chan, Vincent
    Hoey, Andrew
    Brown, Lindsay
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (07) : 902 - 908
  • [42] Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats
    Nunes, VW
    Fortes, ZB
    Nigro, D
    Carvalho, MHC
    Zorn, TMT
    Scivoletto, R
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 2000, 34 (02): : 117 - 125
  • [43] Humoral factors and blood pressure in DOCA-salt hypertensive rats
    Schiffrin, EL
    AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (07) : 825 - 827
  • [44] CARDIOVASCULAR HEMODYNAMICS AND VASOPRESSIN BLOCKADE IN DOCA-SALT HYPERTENSIVE RATS
    YAMAMOTO, J
    YAMANE, Y
    UMEDA, Y
    YOSHIOKA, T
    NAKAI, M
    IKEDA, M
    HYPERTENSION, 1984, 6 (03) : 397 - 407
  • [45] ALTERED CARDIAC NORADRENALINE STORES IN DOCA-SALT HYPERTENSIVE RATS
    HOWE, PRC
    WEST, MJ
    CHALMERS, JP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1981, 8 (01) : 83 - 87
  • [46] The isolated kidney function of DOCA-salt hypertensive rats.
    Dallemagne, CR
    Brown, L
    Endre, ZH
    Oor, SY
    KIDNEY INTERNATIONAL, 1997, 51 (04) : 1307 - 1308
  • [47] UPTAKE AND EFFLUX OF TAURINE IN THE KIDNEY OF DOCA-SALT HYPERTENSIVE RATS
    KIMORI, M
    WAKAMATSU, Y
    OHKUMA, S
    IDA, S
    KURIYAMA, K
    FOLIA PHARMACOLOGICA JAPONICA, 1985, 85 (05) : P69 - P69
  • [48] ALTERED ZINC-METABOLISM IN DOCA-SALT HYPERTENSIVE RATS
    LAURANT, P
    BERTHELOT, A
    TRACE ELEMENTS IN MEDICINE, 1993, 10 (03): : 134 - 136
  • [49] ERYTHROCYTE WATER-CONTENT IN SPONTANEOUSLY HYPERTENSIVE RATS AND DOCA-SALT HYPERTENSIVE RATS
    KAWARABAYASHI, T
    YASUNARI, K
    KANAYAMA, Y
    TAKEUCHI, K
    TAKEDA, T
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1986, 13 (11-12) : 783 - 790
  • [50] Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats
    Chan, Vincent
    Fenning, Andrew
    Iyer, Abishek
    Hoey, Andrew
    Brown, Lindsay
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (03) : 429 - 436